Aspen Pharmacare Stock Forecast, Price & News

Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume2.87 million shs
Average Volume1.87 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A

Receive APN News and Ratings via Email

Sign-up to receive the latest news and ratings for Aspen Pharmacare and its competitors with MarketBeat's FREE daily newsletter.

About Aspen Pharmacare

Aspen Pharmacare Holdings Limited is a South Africa-based supplier and manufacturer of branded and generic pharmaceutical products, as well as infant nutritional and consumer healthcare products. The Company's segments include International, South Africa, Asia Pacific and Sub-Saharan Africa (SSA). Its International business includes operating subsidiaries in Europe, Commonwealth of Independent States (CIS), Latin America, the Middle East and North Africa, Canada, as well as Mauritius-based Aspen Global Incorporated. The South African business provides branded, generic, over-the-counter, consumer health and infant nutritional products, which are supplied to pharmacies, retail pharmacy chains, hospitals, clinics, prescribing specialists, dispensing general practitioners, managed healthcare funders and retail stores across the private and public sectors in South Africa. Its business in Asia Pacific includes operations in Australasia, the Philippines, Taiwan and Japan.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

0.46 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Aspen Pharmacare (AEX:APN) Frequently Asked Questions

What stocks does MarketBeat like better than Aspen Pharmacare?

Wall Street analysts have given Aspen Pharmacare a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Aspen Pharmacare wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Who are Aspen Pharmacare's key executives?

Aspen Pharmacare's management team includes the following people:
  • Stephen Bradley Saad, Group Chief Executive, Executive Director (Age 53)
  • Michael Guy Attridge, Deputy Group Chief Executive, Executive Director (Age 56)
  • Riaan Verster, Company Secretary & Group Governance Officer (Age 41)
  • Kuseni Douglas Dlamini, Non-Executive Chairman of the Board (Age 49)
  • Roy Cecil Andersen CPA, Lead Independent Non-Executive Director (Age 69)
  • Christopher Nattle Mortimer, Non-Executive Director (Age 56)
  • David Redfern, Non-Executive Director (Age 51)
  • John Frederick Buchanan, Non-Executive Independent Director (Age 72)

What is Aspen Pharmacare's stock symbol?

Aspen Pharmacare trades on the AEX under the ticker symbol "APN."

How do I buy shares of Aspen Pharmacare?

Shares of APN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Aspen Pharmacare's official website?

The official website for Aspen Pharmacare is

Where are Aspen Pharmacare's headquarters?

Aspen Pharmacare is headquartered at Woodmead, JOHANNESBURG, 2194, South Africa.

How can I contact Aspen Pharmacare?

Aspen Pharmacare's mailing address is Woodmead, JOHANNESBURG, 2194, South Africa. The company can be reached via phone at +27-11-2396100.

This page was last updated on 6/23/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.